DVA
49
2
DE
45
-3
VNO
49
8
DHI
39
-2
AVY
50
3
CHD
35
3
DG
78
2
CMCSA
32
-10
BBY
50
9
PYPL
52
3
MLM
66
3
GILD
47
-2
DTE
38
-4
KSS
62
2
CTAS
36
8
SE
47
-2
ZBH
47
-9
SLB
48
2
VFC
79
2
LOW
62
4
DVA
49
2
DE
45
-3
VNO
49
8
DHI
39
-2
AVY
50
3
CHD
35
3
DG
78
2
CMCSA
32
-10
BBY
50
9
PYPL
52
3
MLM
66
3
GILD
47
-2
DTE
38
-4
KSS
62
2
CTAS
36
8
SE
47
-2
ZBH
47
-9
SLB
48
2
VFC
79
2
LOW
62
4
Financhill
Back

MDA Space Ltd. 10K Form

Sell
33

MDALF
MDA Space Ltd.

Last Price:
$17.69
Seasonality Move:
-2.7%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MDALF News And Ratings

See the #1 stock for the next 7 days that we like better than MDALF

MDALF Financial Statistics

Sales & Book Value

Annual Sales: $788.4M
Cash Flow: $-26M
Price / Cash Flow: 6.99
Annual Sales: $7.56
Price / Book: 2.37

Profitability

EPS (TTM): 0.61020
Net Income (TTM): $78.2M
Gross Margin: $171.3M
Return on Equity: 8.89%
Return on Assets: 3.73%

MDA Space Ltd. Earnings Forecast

Key MDA Space Ltd. Financial Ratios

  • The Gross Profit Margin over the past 5 years for MDALF is 21.73%.
  • The Selling, General & Administrative Expenses for MDALF have been equal to 7.28% of Gross Profit Margin.
  • The Research & Development expenses have been 7.33% of Revenue.
  • The Interest Expense is 35.26% of Operating Income.
  • The Net Earning history of MDALF is 7.35% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 4 years.

MDA Space Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Aerospace & Defense
Sector: Industrials
Current Symbol: MDALF
Website: mda.space

Debt

Debt-to-Equity Ratio: 0.32
Current Ratio: 0.55
Quick Ratio: 0.46

Price-to-Earnings

Trailing P/E Ratio: 39.05
Forward P/E Ratio: 0

MDALF Technical Analysis vs Fundamental Analysis

Sell
33
MDA Space Ltd. (MDALF) is a Sell

Is MDA Space Ltd. a Buy or a Sell?

  • MDA Space Ltd. stock is rated a Sell
    The current MDA Space Ltd. [MDALF] share price is $17.96. The Score for MDALF is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.